RAD

Rite Aid
NYSE

Real-time Quotes | Nasdaq Last Sale

9.82
-0.13
-1.31%
Closed 19:29 10/20 EDT
OPEN
10.01
PREV CLOSE
9.95
HIGH
10.02
LOW
9.70
VOLUME
2.25M
TURNOVER
--
52 WEEK HIGH
23.88
52 WEEK LOW
7.49
MARKET CAP
542.30M
P/E (TTM)
-1.3913
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Rite Aid to Launch Rite Aid Performance Media Powered by Quotient
Rite Aid (NYSE: RAD) today enhanced its targeted digital media capability through a partnership with the leading digital promotions, media, and analytics company, Quotient, to exclusively connect brands and advertisers to Rite Aid digital customers. At a time when marketers are foregoing traditional channels in favor of more targeted and measurable alternatives, Rite Aid’s customer base represents an important audience with which brands can engage.
Business Wire · 6d ago
Rite Aid Announces New Election Day Work Policy to Encourage Voter Participation
Rite Aid (NYSE: RAD) today announced a new paid time off and flexible hour policy for associates on Election Day, Tuesday, November 3, to ensure that all Rite Aid associates have time to vote and make their voices heard.
Business Wire · 10/13 15:00
These 10 Most Shorted Stocks Are Booming
Stocks with the highest short interest are among the strongest performers over the past month.Retail, Restaurants, and Real Estate are the top targets for short-sellers.Most of these companies have been hit hard by COVID-19 ramifications and are struggling to stop the bleeding.Overall, it seems most high short-interest companies are headed lower in the long-run, but the 'squeeze factor' may continue to temporarily push them higher.Short sellers may want to look away from these companies toward less-crowded short opportunities.
Seekingalpha · 10/12 22:24
Assessing Survival Potential: Rite Aid Corporation
Rite Aid has struggled for about two decades with inconsistent cash flow and profit margins due to growing retail competition.The company's leverage is extremely high, cash flow around zero, and credit rating in the ultra-high-risk territory.Rite Aid's turnaround strategy consists of growing its PBM business and training pharmacists to encourage greater sales.Still, Rite Aid continues to make acquisitions in the face of a poor financial situation, potentially making a bad situation worse.It is still possible that a strategic buyer for Rite Aid shows renewed buyout interest given its low price.
Seekingalpha · 10/12 21:12
Angele Robinson-Gaylord Named Senior Vice President, Store Development at Rite Aid
Rite Aid (NYSE: RAD) has appointed Angele Robinson-Gaylord as senior vice president, store development. She is the latest in a series of senior leaders to join Rite Aid with the skill and imagination to help drive forward Rite Aid’s RxEvolution – the company’s business strategy. Robinson-Gaylord will play a key role in executing and managing renovations for Rite Aid’s Stores of the Future – a critical component of RxEvolution that will transform Rite Aid stores into vibrant destinations for holistic health and wellness.
Business Wire · 10/12 14:46
5 Toxic Stocks That You Should Not be Owning
Figuring out bloated toxic stocks on a consistent basis and discarding them at the right time is the key to successful investing.
Zacks · 10/09 12:32
Rite Aid Ups Game in PBM Space Via Bartell Drugs' Buyout
Rite Aid's (RAD) acquisition deal with Bartell Drugs is likely to strengthen its foothold in mid-market PBM and help boost the RxEvolution strategy.
Zacks · 10/08 15:35
Rite Aid acquires Seattle-area pharmacy chain
In an afternoon announcement, Rite Aid ([[RAD]] +2.7%) says it inked a deal to acquire Bartell Drugs for $95M.Bartell Drugs is a family-owned company that generates over $550M in revenue and
Seekingalpha · 10/07 17:44
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RAD. Analyze the recent business situations of Rite Aid through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RAD stock price target is 8.63 with a high estimate of 13.00 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 217
Institutional Holdings: 44.79M
% Owned: 81.11%
Shares Outstanding: 55.22M
TypeInstitutionsShares
Increased
55
8.27M
New
39
3.07M
Decreased
45
6.34M
Sold Out
104
3.46M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
+0.70%
Food & Drug Retailing
+0.58%
Key Executives
Chairman/Independent Director
Bruce Bodaken
President/Chief Executive Officer/Director
Heyward Donigan
Chief Financial Officer/Senior Vice President
Matthew Schroeder
Chief Operating Officer
Jim Peters
Chief Operating Officer
James Peters
Executive Vice President
Jocelyn Konrad
Executive Vice President
Andre Persaud
Senior Vice President/Chief Information Officer
Justin Mennen
Senior Vice President/Chief Marketing Officer
Erik Keptner
Senior Vice President/Chief Accounting Officer/Treasurer
Matt Schroeder
Senior Vice President/Treasurer/Director of Investor Relations
Trent Kruse
Senior Vice President
Chris Bohrer
Senior Vice President
Angele Robinson-Gaylord
Senior Vice President
Roxanne Schwans
Chief Accounting Officer
Brian Hoover
General Counsel/Secretary
Paul Gilbert
Independent Director
Elizabeth Burr
Independent Director
Bari Harlam
Independent Director
Robert Knowling
Independent Director
Kevin Lofton
Independent Director
Louis Miramontes
Independent Director
Arun Nayar
Independent Director
Katherine Quinn
Independent Director
Marcy Syms
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
10/07/1999
Dividend USD 0.115
10/14/1999
06/30/1999
Dividend USD 0.115
07/15/1999
04/07/1999
Dividend USD 0.115
04/15/1999
01/13/1999
Dividend USD 0.115
01/15/1999
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About RAD
Rite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Rite Aid Corporation stock information, including NYSE:RAD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RAD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RAD stock methods without spending real money on the virtual paper trading platform.